Cargando…
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors
Cisplatin reacts with DNA and thereby likely generates a characteristic pattern of somatic mutations, called a mutational signature. Despite widespread use of cisplatin in cancer treatment and its role in contributing to secondary malignancies, its mutational signature has not been delineated. We hy...
Autores principales: | Boot, Arnoud, Huang, Mi Ni, Ng, Alvin W.T., Ho, Szu-Chi, Lim, Jing Quan, Kawakami, Yoshiiku, Chayama, Kazuaki, Teh, Bin Tean, Nakagawa, Hidewaki, Rozen, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932606/ https://www.ncbi.nlm.nih.gov/pubmed/29632087 http://dx.doi.org/10.1101/gr.230219.117 |
Ejemplares similares
-
Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types
por: Boot, Arnoud, et al.
Publicado: (2020) -
Accuracy of mutational signature software on correlated signatures
por: Wu, Yang, et al.
Publicado: (2022) -
Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines
por: Chayama, Kazuaki, et al.
Publicado: (2012) -
Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors
por: Huang, Mi Ni, et al.
Publicado: (2017) -
HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients
por: Canini, Laetitia, et al.
Publicado: (2017)